Mark R Nehler (Mark Nehler)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Extracorporeal Membrane Oxygenation

Peripheral Artery Disease

Top Venues

European heart journal

European journal of preventive cardiology

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Scott D Berkowitz, Rupert M Bauersachs, Michael Szarek, Mark R Nehler, Eike Sebastian Debus, Manesh R Patel, Sonia S Anand, Warren H Capell, Connie N Hess, Judith Hsia, Nicholas J Leeper, David De Padua Brasil, Lajos Mátyás, Rafael Diaz, Marianne Brodmann, Eva Muehlhofer, Lloyd P Haskell, Marc P Bonaca
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Sonia S Anand, Will Hiatt, Leanne Dyal, Rupert M Bauersachs, Scott D Berkowitz, Kelley R H Branch, Sebastian Debus, Keith A A Fox, Yan Liang, Eva Muehlhofer, Mark R Nehler, Lloyd P Haskell, Manesh Patel, Michael Szarek, Salim Yusuf, John William Eikelboom, Marc P Bonaca
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. European journal of preventive cardiology (2021)
Mori J Krantz, Sebastian E Debus, Judith Hsia, Manesh R Patel, Sonia S Anand, Mark R Nehler, Connie N Hess, Warren H Capell, Taylor Bracken, Michael Szarek, Lajos Mátyás, Dainis K Krievins, Patrice Nault, Stefan Stefanov, Lloyd P Haskell, Scott D Berkowitz, Eva Muehlhofer, William R Hiatt, Rupert M Bauersachs, Marc P Bonaca
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial. European heart journal 42 (39) (2021)